A világ népessége, a születéskor várható élettartam és ezzel együtt az idősek aránya a népességen belül visszafordíthatatlanul növekszik. Ez a trend a belátható időn belül megfordíthatatlannak látszik, aminek jelentős egészségügyi kihatásai vannak. Az idősek körében aránytalanul magasabb az endokrin és anyagcsere-betegségek prevalenciája. Az idősek patofiziológiai paraméterei jelentősen eltérnek a fiatal felnőttekéitől, aminek következtében morbiditási „mintázatuk” is más. A hypopituitarismus, a hypothyreosis, az osteoporosis, a diabetes mellitus, a mellékvesekéreg-elégtelenség, a hypogonadismus különböző formái, a malignus endokrin betegségek gyakoribbak idősekben. Nagy figyelmet igényel, hogy időskorban a hormonok laboratóriumi értékei általában „normálisan” alacsonyabbak a standardoknál. A kezelés során ennek a korcsoportnak az adottságait fontos tényezőként kell figyelembe venni, hogy optimális eredményt érhessünk el. A belgyógyászat és az endokrinológia oktatása során az időskorra vonatkozó eltéréseknek fokozott hangsúlyt kellene kapniuk a graduális képzés idején. Orv Hetil. 2024; 165(2): 51–58.
The population of the world, the life expectancy at birth and the proportion of elderly in the population increase irreversibly. This trend seems irreversible and has significant importance in healthcare. The endocrine and metabolic diseases’ prevalence is disproportionately higher in elderly people. Their pathophysiological properties also highly differ from younger counterparts, resulting in altered morbidity patterns. The hypopituitarism, hypothyroidism, osteoporosis, diabetes mellitus, insufficiency of adrenal glands, different types of hypogandism and malignant endocrine diseases appear more frequently in old people. It should be highlighted that distinct hormonal laboratory findings in the elderly are normally lower than standard ones. It is an important factor to take into consideration the capability of this age-group during disease treatment to get optimal result. During the gradual education of endocrinology and internal medicine, the highlighting of the alteration of old people should be more focused. Orv Hetil. 2024; 165(2): 51–58.
United Nations, Digital Library. Recommended standard international age classifications for demographic, social and related economic data. In: Provisional Guidelines on standard international age classification. Statistical Papers, United Nations, New York, NY, 1982; pp. 3–12. Available from: https://digitallibrary.un.org/record/32113 [accessed: Nov 6, 2023].
Lelbach Á, Székács B. Biological and physiological aspects of ageing. In: Székács B. (ed.) Geriatry. [Az öregedés biológiai és élettani vonatkozásai. In: Székács B. (szerk.) Geriátria: az időskor gyógyászata.] Semmelweis Kiadó, Budapest, 2005; pp. 7–13. [Hungarian]
Yang H, Fang B, Wang Z, et al. The timing sequence and mechanism of ageing in endocrine organs. Cells 2023; 12: 982.
Russell SJ, Kahn CR. Endocrine regulation of ageing. Nat Rev Mol Cell Biol. 2007; 8: 681–691.
Veldhuis JD. Changes in pituitary function with ageing and implications for patient care. Nat Rev Endocrinol. 2013; 9: 205–215.
Diamanti-Kandarakis E, Dattilo M, Macut D, et al. Mechanisms in endocrinology. Aging and anti-aging: a Combo-Endocrinology overview. Eur J Endocrinol. 2017; 176: R283–R308.
Mattis J, Sehgal A. Circadian rhythms, sleep, and disorders of aging. Trends Endocrinol Metab. 2016: 27: 192–203.
Ferrari E, Cravello L, Muzzoni B, et al. Age-related changes of the hypothalamic-pituitary-adrenal axis: pathophysiological correlates. Eur J Endocrinol. 2001; 144: 319–329.
Junnila RK, List EO, Berryman DE, et al. The GH/IGF-1 axis in ageing and longevity. Nat Rev Endocrinol. 2013; 9: 366–376.
Gibney J, Wolthers T, Johannsson G, et al. Growth hormone and testosterone interact positively to enhance protein and energy metabolism in hypopituitary men. Am J Physiol Endocrinol Metab. 2005; 289: E266–E271.
Canaris GJ, Manowitz NR, Mayor G, et al. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000; 160: 526–534.
Roelfsema F, Pijl H, Keenan DM, et al. Prolactin secretion in healty adults is determined by gender, age and body mass index. PLOS ONE 2012; 7: e31305.
Tian Y, Serino R, Verbalis JG. Downregulation of renal vasopressin V2 receptor and aquaporin-2 expression parallels age-associated defects in urine concentration. Am J Physiol Renal Physiol. 2004; 287: F797–F805.
Bauer JH. Age related changes in the renin-aldosterone system. Physiological effects and clinical implications. Drugs Aging 1993; 3: 238–245.
Boelaert K. Thyroid dysfunction in the elderly. Nat Rev Endocrinol. 2013; 9: 194–204.
Peeters RP. Thyroid hormones and aging. Hormones (Athens) 2008; 7: 28–35.
Rosario PW. Natural history of subclinical hyperthyroidism in elderly patients with TSH between 0.1 and 0.4 mIU/l: a prospective study. Clin Endocrinol. (Oxf) 2010; 72: 685–688.
Ross DS, Burch HB, Cooper DS. 2016 American Thyroid Association Guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid 2016; 26: 1343–1421. Erratum: Thyroid 2017; 27: 1462.
Roberts CG, Ladenson PW. Hypothyreoidism. Lancet 2004; 363: 793–803.
Bogazzi F, Bartalena L, Martino E. Approach to the patient with amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab. 2010; 95: 2529–2535.
Carlé A, Laurberg P, Pedersen IB, et al. Age modifies the pituitary TSH response to thyroid failure. Thyroid 2007; 17: 139–144.
Franklyn JA. The thyroid – too much and too little across ages. The conseqences of subclinical thyroid dysfunction. Clin Endocrinol. (Oxf) 2013; 78: 1–8.
Shamonki IM, Frumar AM, Tataryn IV, et al. Age-related changes of calcitonin secretion in females. J Clin Endocrinol Metab. 1980; 50: 437–439.
Portale AA, Lonergan ET, Tanney DM, et al. Aging alters calcium regulation of serum concentration of parathyroid hormone in healthy men. Am J Physiol. 1997; 272: E139–E146.
Braverman ER, Chen TJ, Chen AL, et al. Age related increases in parathyroid hormone may be antecedent to both osteoporosis and dementia. BMC Endocr Disord. 2009; 9: 21.
Tuohimaa P. Vitamin D and aging. J Steroid Biochem Mol Biol. 2009; 114: 78–84.
Detection, prevention and treatment of osteoporosis. Recommendation of the Hungarian Society for Osteology and Osteoarthrology. [MOOT. Az osteoporosis felismerése, megelőzése és kezelése. A Magyar Osteoporosis és Osteoarthrológiai Társaság szakmai ajánlása.] Ca Csont 2008; 11: 4–62. [Hungarian]
Tardi P. Study on the disease-specific knowledge and the significance of patient’ education in physiotherapy. Analysis of osteoporosis-specific knowledge. [A betegség-specifikus tudás vizsgálata és a betegedukáció jelentősége a fizioterápiában – az osteoporosis betegség-specifikus tudás vizsgálata.] Doktori (PhD-) értekezés. Pécsi Tudományegyetem, Egészségtudományi Doktori Iskola, Pécs, 2023.
Szathmári M. Osteoporosis. In: Leövey A, Nagy VE, Paragh Gy, Rácz K. (eds.) Textbook of endocrine and metabolic disorders. [Osteoporosis. In: Leövey A, Nagy VE, Paragh Gy, Rácz K. (szerk.) Az endokrin és anyagcsere-betegségek gyakorlati kézikönyve.] Medicina Könyvkiadó, Budapest, 2017; pp. 239–262. [Hungarian]
Zaidi SK, Shen WJ, Azhar S. Impact of aging on steroid hormone biosynthesis and secretion. Open Longev Sci. 2012; 6: 1–30.
Liamis G, Milionis G, Elisaf M. A review of drug-induced hyponatremia. Am J Kidney Dis. 2008; 52: 144–153.
Miller M. Chapter 17: Fluid balance disorders in the elderly. Geriatric Nephrology Curriculum, American Society of Nephrology, Washington, DC, 2009. Available from: https://www.asn-online.org/education/distancelearning/curricula/geriatrics/Chapter17.pdf [accessed: Oct 10, 2023].
Baulieu EE, Thomas G, Legrain S. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge study to a sociobiomedical issue. Proc Natl Acad Sci USA 2000; 97: 4279–4284.
Seals DR, Esler MD. Human ageing and the sympathoadrenal system. J Physiol. 2000; 528: 407–417.
El Khoudary SR, McClure CK, VoPham T, et al. Longitudinal assessment of the menopausal transition endogenous sex hormones, and perception, of physical functioning: the Study of Women’s Health Across the Nation. J Gerontol A Biol Sci Med Sci. 2014; 69: 1011–1017.
Veldhuis JD, Sharma A, Roelfsema F. Age-dependent and gender-dependent regulation of hypothalamic-adrenocorticotropic-adrenal axis. Endocrinol Metab Clin North Am. 2013; 42: 201–225.
Cunningham GR. Andropause or male menopause? Rationale for testosterone replacement therapy in older men with low testosterone levels. Endocr Pract. 2013; 19: 847–852.
El-Sakka AI, Hassoba HM. Age related testosterone depletion in patients with erectile dysfunction. J Urol. 2006; 176: 2589–2593.
Vigen R, O’Donnell CI, Barón AE, et al. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA 2013; 310: 1829–1836. Erratum: JAMA 2014; 311: 967
Jakab A. Endocrine disorders of reproductive system in women. In: Nagy VE. (ed.) Endocrine disorders in adults. [A reproduktív rendszer endokrin betegségei nőkben. In: Nagy VE. (szerk.) Endokrin betegségek felnőttkorban.] Medicina Könyvkiadó, Budapest; 2021; pp. 180–198. [Hungarian]
Janicki SC, Schupf N. Hormonal influences on cognition and risk for Alzheimer’s disease. Curr Neurol Neurosci Rep. 2010; 10: 359–366.
Changes of the endocrine system and metabolism. In: Kvell K, Pongrácz J, Székely M, et al. Molecular and clinical basis of gerontology. [Az endokrin rendszer és az anyagcsere változásai. In: Kvell K, Pongrácz J, Székely M, et al. A gerontológia molekuláris és klinikai alapjai. TÁMOP-4.1.2-08/1/A-2009-0011] Pécsi Tudományegyetem, Pécs, 2011; pp. 74–78. [Hungarian]